Pancreatic cancer remains a formidable foe, with the American Cancer Society estimating over 66,000 ... ONCY) (TSX: ONC), GSK plc (NYSE: GSK), AstraZeneca PLC (NASDAQ: AZN), Gilead Sciences ...
Many gynecological cancer patients face barriers to treatment and support. This Westchester woman helped uncover the gaps and seek solutions.
The results were featured at the American Society of Haematology (ASH) annual meeting and, according to GSK, "support the potential ... treatment for the blood cancer. After being all but written ...
GSK isn't revealing the size of the OS improvement yet – it has promised to do so at the American Society for Haematology ... At this year's ASCO cancer congress in February, earlier results ...
After systematically testing 152 drug response profiles and 11,476 drug combinations, we identified the combination of kinase inhibitors QL-XII-47 and GSK-690693 as the topmost ... M.L.K and D.O), the ...
By sharing the stories of EDI champions in science, we hope to shed light on both the importance of diversity and the ...
First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant metastatic colorectal cancer (mCRC), according to the BREAKWATER trial. The study ...
Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT ...
The majority (41 of 53) of patients had their autoimmune or inflammatory disease diagnosed before cancer. The study was approved by ... T-cell therapy using paired McNemar's tests. ASTCT=American ...
In 2000, the Union for International Cancer Control (UICC) named Feb. | In 2000, the Union for International Cancer Control named Feb. 4 World Cancer Day, with a goal of raising awareness of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results